Yonghe Medical Group Valuation
Is 2279 undervalued compared to its fair value, analyst forecasts and its price relative to the market?
Valuation Score
3/6Valuation Score 3/6
Por debajo del valor justo
Muy por debajo del valor justo
Price-To-Sales vs. similares
Price-To-Sales vs. Industria
PM vs. Ratio Justo
Pronóstico de los analistas
Share Price vs Fair Value
What is the Fair Price of 2279 when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.
Por debajo del valor justo: Datos insuficientes para calcular el valor razonable de 2279 para el análisis de valoración.
Muy por debajo del valor justo: Datos insuficientes para calcular el valor razonable de 2279 para el análisis de valoración.
Key Valuation Metric
Which metric is best to use when looking at relative valuation for 2279?
Other financial metrics that can be useful for relative valuation.
What is 2279's n/a Ratio? | |
---|---|
n/a | 0x |
n/a | n/a |
Market Cap | CN¥559.86m |
Key Statistics | |
---|---|
Enterprise Value/Revenue | 0.6x |
Enterprise Value/EBITDA | -8.6x |
PEG Ratio | n/a |
Price to Sales Ratio vs Peers
How does 2279's PS Ratio compare to its peers?
Company | Forward PS | Estimated Growth | Market Cap |
---|---|---|---|
Peer Average | 1.4x | ||
3689 Guangdong Kanghua Healthcare | 0.3x | n/a | HK$705.6m |
383 China Medical & HealthCare Group | 0.5x | n/a | HK$716.8m |
2189 Kato (Hong Kong) Holdings | 1.7x | n/a | HK$560.0m |
1989 Pine Care Group | 3x | n/a | HK$812.6m |
2279 Yonghe Medical Group | 0.3x | 17.6% | HK$605.9m |
Price-To-Sales vs. similares: 2279 es un buen valor basado en su Ratio Price-To-Sales (0.5x) comparado con la media de sus homólogos (0.5x).
Price to Earnings Ratio vs Industry
How does 2279's PE Ratio compare vs other companies in the HK Healthcare Industry?
Price-To-Sales vs. Industria: 2279 es un buen valor basado en su Ratio Price-To-Sales (0.9x) comparado con la media del sector Hong Kong Healthcare (1.1x).
Price to Sales Ratio vs Fair Ratio
What is 2279's PS Ratio compared to its Fair PS Ratio? This is the expected PS Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.
Fair Ratio | |
---|---|
Current PS Ratio | 0.3x |
Fair PS Ratio | 1.6x |
PM vs. Ratio Justo: 2279 es un buen valor basado en su Ratio Price-To-Sales (0.9x) comparado con el Ratio estimado Fair Price-To-Sales (3.7x).
Analyst Price Targets
What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?
Pronóstico de los analistas: Datos insuficientes para mostrar el pronóstico de precios.